Skip to main content

Advertisement

Log in

Manifestation of meibomian gland dysfunction in patients with Sjögren’s syndrome, non-Sjögren’s dry eye, and non-dry eye controls

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the manifestation of meibomian gland dysfunction in patients with Sjögren’s syndrome (SS), non-Sjögren’s syndrome dry eye (non-SS) patients, and non-dry eye controls.

Methods

We recruited 31 participants with SS dry eye, 30 participants with non-SS dry eye, and 35 healthy controls without dry eye symptoms. Noninvasive tear breakup time (NITBUT) and meibomian gland dropout score (meiboscore) were measured using the Oculus Keratograph 5 M. Meibomian gland expressibility and secretion quality were evaluated via slit lamp biomicroscopy. The correlation between measurements was analyzed.

Results

NITBUT was lower, and the meiboscore, meibomian gland expressibility, and secretion quality scores were significantly higher in the SS and non-SS groups than in the control group (p < 0.001). NITBUT was lower, and the meiboscore and meibomian gland expressibility were higher in the SS group than in the non-SS group. NITBUT correlated negatively with the meiboscore in both SS and non-SS groups and with meibomian gland expressibility in the SS group. A positive correlation was obtained between meiboscore and meibomian gland expressibility in both the SS and the non-SS groups.

Conclusion

Patients in both SS and non-SS groups exhibited greater impairment in meibomian gland function than the non-dry eye controls. SS patients had more severe meibomian gland dysfunction with poorer mean meiboscore and meibomian gland expressibility than non-SS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. LEMP MA, Baudouin C, Baum J et al (2007) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 5(2):75–92

  2. Choi W, Li Z, Oh H-J et al (2012) Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease. Curr Eye Res 37(1):12–17

    Article  PubMed  CAS  Google Scholar 

  3. Yoon K-C, Park C-S, You I-C et al (2010) Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest Ophthalmol Vis Sci 51(2):643–650

    Article  PubMed  PubMed Central  Google Scholar 

  4. Yoon K-C, Ahn K-Y, Choi W et al (2011) Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress. Invest Ophthalmol Vis Sci 52(10):7267–7273

    Article  PubMed  Google Scholar 

  5. Jonsson R, Vogelsang P, Volchenkov R et al (2011) The complexity of Sjögren’s syndrome: novel aspects on pathogenesis. Immunol Lett 141(1):1–9

    Article  PubMed  CAS  Google Scholar 

  6. Caffery B, Simpson T, Wang S et al (2010) Factor analysis of the clinical characteristics of primary Sjogren syndrome. Optom Vis Sci 87(10):742–750

    Article  PubMed  Google Scholar 

  7. Jung HH, Ji YS, Sung MS et al (2015) Long-term outcome of treatment with topical corticosteroids for severe dry eye associated with Sjögren’s syndrome. Chonnam Med J 51(1):26–32

    Article  PubMed  PubMed Central  Google Scholar 

  8. Nelson JD, Shimazaki J, Benitez-del-Castillo JM et al (2011) The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52(4):1930–1937

    Article  PubMed  PubMed Central  Google Scholar 

  9. Srinivasan S, Menzies K, Sorbara L et al (2012) Infrared imaging of meibomian gland structure using a novel keratograph. Optom Vis Sci 89(5):788–794

    Article  PubMed  Google Scholar 

  10. Bron AJ, Tiffany JM (2004) The contribution of meibomian disease to dry eye. Ocul Surf 2(2):149–165

    Article  PubMed  CAS  Google Scholar 

  11. Knop E, Knop N, Millar T et al (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 52(4):1938–1978

    Article  PubMed  PubMed Central  Google Scholar 

  12. Goto E, Matsumoto Y, Kamoi M et al (2007) Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients. Am J Ophthalmol 144(1):81–85

    Article  PubMed  Google Scholar 

  13. Shimazaki J, Goto E, Ono M et al (1998) Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology 105(8):1485–1488

    Article  PubMed  CAS  Google Scholar 

  14. Menzies KL, Srinivasan S, Prokopich CL et al (2015) Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren’s syndrome patients and nondry eye controls. Invest Ophthalmol Vis Sci 56(2):836–841

    Article  PubMed  Google Scholar 

  15. Arita R, Itoh K, Inoue K, Amano S (2008) Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 115(5):911–915

    Article  PubMed  Google Scholar 

  16. Shiboski SC, Shiboski CH, Criswell LA et al (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res 64(4):475–487

    Article  CAS  Google Scholar 

  17. Baek J, Doh SH, Chung SK (2015) Comparison of tear meniscus height measurements obtained with the keratograph and Fourier domain optical coherence tomography in dry eye. Cornea 34(10):1209–1213

    Article  PubMed  Google Scholar 

  18. Tomlinson A, Bron AJ, Korb DR et al (2011) The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 52(4):2006–2049

    Article  PubMed  PubMed Central  Google Scholar 

  19. Yoon K-C, Im S-K, Kim H-G et al (2011) Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome. Cornea 30(9):972–976

    Article  PubMed  Google Scholar 

  20. Shine WE, McCulley JP (1998) Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol 116:849–852

    Article  PubMed  CAS  Google Scholar 

  21. Pflugfelder SC, Huang AJ, Feuer W et al (1990) Conjunctival cytologic features of primary Sjögren’s syndrome. Ophthalmology 97(8):985–991

    Article  PubMed  CAS  Google Scholar 

  22. Hikichi T, Yoshida A, Tsubota K (1993) Lymphocytic infiltration of the conjunctiva and the salivary gland in Sjögren’s syndrome. Arch Ophthalmol 111(1):21–22

    PubMed  CAS  Google Scholar 

  23. Bloch KJ, Buchanan WW et al (1992) Sjögren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 71(6):386–401

    Article  CAS  Google Scholar 

  24. Jester JV, Nicolaides N, Smith RE (1981) Meibomian gland studies: histologic and ultrastructural investigations. Invest Ophthalmol Vis Sci 20(4):537–547

    PubMed  CAS  Google Scholar 

  25. Jester JV, Rife L, Nii D et al (1982) In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 22(5):660–667

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was partially supported by the CNUH Biomedical Research Institute (CRI 13906-22).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyung Chul Yoon.

Ethics declarations

Conflict of interest

The authors disclose absence of commercial or propriety interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, Y.S., Lee, H.S., Li, Y. et al. Manifestation of meibomian gland dysfunction in patients with Sjögren’s syndrome, non-Sjögren’s dry eye, and non-dry eye controls. Int Ophthalmol 38, 1161–1167 (2018). https://doi.org/10.1007/s10792-017-0577-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-017-0577-4

Keywords

Navigation